Cargando…

N(6)-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC

PURPOSE: N(6)-methyladenosine (m(6)A) modification has shown critical roles in regulating mRNA fate. Non-coding RNAs also have important roles in various diseases, including hepatocellular carcinoma (HCC). However, the potential influences of m(6)A modification on non-coding RNAs are still unclear....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Chuan, Huang, Yanyan, Huang, Zheng, Ning, Yuanjia, Huang, Lizheng, Wu, Xianjian, Lu, Yuan, Wei, Huamei, Pu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493143/ https://www.ncbi.nlm.nih.gov/pubmed/37701563 http://dx.doi.org/10.2147/JHC.S415318

Ejemplares similares

N(6)-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling
por: Wei, Huamei, et al.
Publicado: (2023)

N(6) ‐methyladenosine‐modified FAM111A‐DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A
por: Pu, Jian, et al.
Publicado: (2023)

LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma
por: Wei, Qing, et al.
Publicado: (2023)

m(6)A modification of AC026356.1 facilitates hepatocellular carcinoma progression by regulating the IGF2BP1-IL11 axis
por: Wei, Huamei, et al.
Publicado: (2023)

Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1
por: Pu, Jian, et al.
Publicado: (2021)

Long Noncoding RNA PART1 Promotes Hepatocellular Carcinoma Progression via Targeting miR-590-3p/HMGB2 Axis
por: Pu, Jian, et al.
Publicado: (2020)

N(6)‐methyladenosine‐modified lncRNA ARHGAP5‐AS1 stabilises CSDE1 and coordinates oncogenic RNA regulons in hepatocellular carcinoma
por: Liu, Jiandong, et al.
Publicado: (2022)

CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma()
por: Yang, Yu-Feng, et al.
Publicado: (2018)

miR‐584‐5p regulates hepatocellular carcinoma cell migration and invasion through targeting KCNE2
por: Wei, Huamei, et al.
Publicado: (2019)

Hypoxia-induced Fascin-1 upregulation is regulated by Akt/Rac1 axis and enhances malignant properties of liver cancer cells via mediating actin cytoskeleton rearrangement and Hippo/YAP activation
por: Pu, Jian, et al.
Publicado: (2021)

Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs
por: Ciaccio, Roberto, et al.
Publicado: (2021)

The Epigenetic Regulation of RNA N6-Methyladenosine Methylation in Glycolipid Metabolism
por: Yang, Haiqing, et al.
Publicado: (2023)

HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way
por: Wu, Xianjian, et al.
Publicado: (2023)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
por: Cheng, Wenli, et al.
Publicado: (2022)

N6-methyladenosine associated prognostic model in hepatocellular carcinoma
por: Huang, Hanchun, et al.
Publicado: (2020)

ANXA1 (Annexin A1) regulated by MYC (MYC proto-oncogene) promotes the growth of papillary thyroid carcinoma
por: Ying, Xiaomei, et al.
Publicado: (2021)

Normalization of the ATP1A1 Signalosome Rescinds Epigenetic Modifications and Induces Cell Autophagy in Hepatocellular Carcinoma †
por: Rajan, Pradeep Kumar, et al.
Publicado: (2023)

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
por: Sharma, Nitesh, et al.
Publicado: (2015)

Important oncogenic and immunogenic roles of SPP1 and CSF1 in hepatocellular carcinoma
por: Xiang, Tianxin, et al.
Publicado: (2023)

lncRNA TMPO-AS1 Exerts Oncogenic Roles in HCC Through Regulating miR-320a/SERBP1 Axis
por: Wang, Zhenchang, et al.
Publicado: (2020)

Heat Shock Protein 90α–Dependent B‐Cell‐2–Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto‐Oncogene c‐MYC mRNA Stability
por: Zhou, Xueqiong, et al.
Publicado: (2018)

Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer
por: González, Beatriz, et al.
Publicado: (2018)

Oncogenic MYC amplifies mitotic perturbations
por: Littler, Samantha, et al.
Publicado: (2019)

Epigenetic regulation of N6‐methyladenosine modifications in obesity
por: Sun, Mingli, et al.
Publicado: (2021)

lncRNA MAGI2-AS3 Prevents the Development of HCC via Recruiting KDM1A and Promoting H3K4me2 Demethylation of the RACGAP1 Promoter
por: Pu, Jian, et al.
Publicado: (2019)

Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma
por: Ragusa, Federica, et al.
Publicado: (2021)

EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC
por: Yin, Yalei, et al.
Publicado: (2019)

Polyploidy and Myc Proto-Oncogenes Promote Stress Adaptation via Epigenetic Plasticity and Gene Regulatory Network Rewiring
por: Anatskaya, Olga V., et al.
Publicado: (2022)

Coamplification of the L‐myc and N‐myc Oncogenes in a Neuroblastoma Cell Line
por: Jinbo, Takeshi, et al.
Publicado: (1989)

Hyperphosphorylated PTEN exerts oncogenic properties
por: van Ree, Janine H., et al.
Publicado: (2023)

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics
por: ZIMONJIC, DRAZEN B., et al.
Publicado: (2012)

Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1
por: Luo, Wenzheng, et al.
Publicado: (2019)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

Myc, Oncogenic Protein Translation, and the Role of Polyamines
por: Flynn, Andrea T., et al.
Publicado: (2018)

TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis
por: Zhou, Y, et al.
Publicado: (2017)

Androgen-Responsive Oncogenic lncRNA RP11-1023L17.1 Enhances c-Myc Protein Stability in Prostate Cancer
por: Huang, Wenhua, et al.
Publicado: (2022)

High Intrinsic Oncogenic Potential in the Myc-Box-Deficient Hydra Myc3 Protein
por: Lechable, Marion, et al.
Publicado: (2023)

Long noncoding RNA UFC1 is activated by E2F1 and exerts oncogenic properties by functioning as a ceRNA of FOXP3
por: Xi, Jie, et al.
Publicado: (2018)

Expression of the c-myc Proto-oncogene Is Essential for HIV-1 Infection in Activated T Cells
por: Sun, Yu, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_ogqsnlh6843qco9q95kfja962p